Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:morphine_sulfate
|
| gptkbp:ATCCode |
N02AA01
|
| gptkbp:brand |
gptkb:morphine_sulfate_extended-release
|
| gptkbp:controlledSubstanceSchedule |
gptkb:Schedule_II_(US)
|
| gptkbp:discontinued |
2017
|
| gptkbp:form |
capsule
|
| https://www.w3.org/2000/01/rdf-schema#label |
Avinza
|
| gptkbp:indication |
chronic pain
|
| gptkbp:legalStatus |
prescription only (Rx)
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:marketWithdrawalStatus |
discontinued (US)
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:regulates |
approved
|
| gptkbp:riskFactor |
addiction
overdose respiratory depression |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:usedFor |
pain management
|
| gptkbp:bfsParent |
gptkb:Morphine
|
| gptkbp:bfsLayer |
6
|